A nurse displays a vial of the Comirnaty by BioNTech/Pfizer vaccine against the coronavirus disease (COVID-19) at a vaccination centre in Berlin, Germany, January 1, 2022. REUTERS/Michele Tantussi

Pfizer, BioNTech propose EU pays half for each cancelled COVID dose – FT

Pfizer Inc and BioNTech’s new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay half price, or about 10 euros ($11), for…

Read More

Moderna sues Pfizer, BioNTech over Covid vaccine

Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot administered to hundreds of millions around…

Read More
A vial labelled “Pfizer COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration

Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine

NEW YORK, Jan 25 (Reuters) – Pfizer Inc. and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target…

Read More
REUTERS/Dado Ruvic/Illustration

Pfizer, BioNTech vaccine neutralises Omicron with three shots

(Reuters) – BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test, an early signal that…

Read More
REUTERS/Brendan McDermid

Pfizer’s COVID-19 vaccine trial data shows long-term efficacy in adolescents

Nov 22 (Reuters) – Pfizer Inc. said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15…

Read More
AP Photo/David Goldman, File

Pfizer says COVID-19 vaccine works in kids ages 5 to 11

(AP) – Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key…

Read More
AP Photo/Charles Krupa, File

Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market

NEW YORK (Reuters) – Drug makers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID–19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts…

Read More
Photo by JACK GUEZ / AFP

BioNTech produces 10 times more antibodies than Sinovac: Hong Kong study

Hong Kong, China (AFP) – People who received BioNTech’s coronavirus vaccine had ten times the amount of antibodies than those given China’s Sinovac, a Hong Kong study has shown, adding to growing…

Read More

Are Pfizer shots the cure for Thailand’s COVID crisis?

Despite being the most talked about and sought-after vaccine in Thailand, not a single dose of Pfizer-BioNTech has been administered here to date. The Pfizer jab’s efficacy is impressively high…

Read More
Photo by THOMAS KIENZLE / AFP

Covid jab maker BioNTech to build SE Asia manufacturing site in Singapore

Covid jab maker BioNTech said Monday it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of mRNA-based vaccines per year. Construction of…

Read More
A teenager receives a dose of the Pfizer-BioNtech COVID-19 coronavirus vaccine at Clalit Health Services, in Israel’s Mediterranean coastal city of Tel Aviv. (Photo by JACK GUEZ / AFP)

Pfizer/BioNTech seek Covid jab approval for 12-15-year-olds in EU

Pfizer/BioNTech said Friday they have asked European regulators to authorize their Covid-19 vaccine for 12- to 15-year-olds, a move seen as a crucial step toward achieving herd immunity. The companies…

Read More

Page 1 of 1

Login

Welcome! Login in to your account

Remember me Lost your password?

Lost Password